Please sign in to follow a disease.
Can we predict Crohn's damage before it happens? a Long-Term study aims to find out
NCT ID NCT05420233
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This study follows people newly diagnosed with Crohn's disease for up to five years to see how the condition damages the bowel over time. Researchers will use imaging scans and other tests to track disease progression and understand how different treatments affect long-term outcomes. The goal is to develop better ways to predict and prevent permanent bowel damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict which treatments best prevent long-term bowel damage in Crohn's disease.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not directly test a new therapy. Results depend on careful follow-up over many years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Algomed Policlinic
Timișoara, Romania
-
American Gastroenterology Center
Stróvolos, Cyprus
-
Azienda Ospedaliera di Padova
Padova, Italy
-
CHU Amiens-Picardie Hôpital Sud
Amiens, France
-
CHU Estaing Clermont - Ferrand
Clermont-Ferrand, France
-
Claude Huriez Hospital, Lille University
Lille, France
-
Hospital Alvaro Cunqueiro - Área Sanitária de Vigo
Vigo, Spain
-
Hospital Beatriz Angelo
Loures, Loures, Portugal
-
Hospital Clinic Barcelona
Barcelona, Spain
-
Hospital Galdakao-Usansolo
Galdakao, Spain
-
Hospital Garcia da Orta
Almada, Almada, Portugal
-
Hull University Teaching Hospitals NHS Trust
Hull, United Kingdom
-
Hvidovre Hospital
Hvidovre, Denmark
-
IBD Clinical and Research Clinic, ISCARE
Prague, Czechia
-
Instituto Portugues de Oncologia de Lisboa
Lisbon, Lisbon District, Portugal
-
Mater dei hospital
Msida, Malta
-
Slagelse Hospital
Slagelse, Denmark
-
St Mark's Hospital
London, United Kingdom
-
University Hospital CHU of Liège
Liège, Liège, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?